TFS CAPITAL LLC - INOTEK PHARMACEUTICALS CORP ownership

INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102. A total of 86 filers reported holding INOTEK PHARMACEUTICALS CORP in Q4 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.

Quarter-by-quarter ownership
TFS CAPITAL LLC ownership history of INOTEK PHARMACEUTICALS CORP
ValueSharesWeighting
Q3 2016$223,000
-47.4%
23,517
-58.7%
0.05%
-32.1%
Q2 2016$424,000
+38.6%
56,936
+74.8%
0.08%
+160.0%
Q3 2015$306,00032,5640.03%
Other shareholders

There were no reported owners of INOTEK PHARMACEUTICALS CORP in Q4 2016.

NameSharesValueWeighting ↓
View complete list of INOTEK PHARMACEUTICALS CORP shareholders